通过AcrIIA2626抑制CRISPR-SpyCas9的分子机制
Ziqi Zhen1, Ling Yu1, Yuwei Zhu1
1HIT Center for Life Sciences, School of Life Science and Technology, Harbin Institute of Technology, Harbin, 150080, China.
Biochemical and biophysical research communications
|February 22, 2026
概括
一种新型的抗CRISPR蛋白,AcrIIA26,通过阻止DNA结合来抑制Streptococcus pyogenes Cas9 (SpyCas9). 它的sgRNA独立机制允许扩展基因编辑控制.
科学领域:
- 分子生物学分子生物学
- 微生物遗传学 微生物遗传学
- 生物化学 生物化学
背景情况:
- 克里斯普尔-卡斯系统和抗克里斯普尔蛋白 (Acrs) 是细菌菌体进化军备竞赛中的关键参与者.
- 来自Streptococcus sp. 的 AcrIIA26 病毒. 调节SpyCas9活动,但其机制尚不清楚.
研究的目的:
- 为了阐明AcrIIA26抑制SpyCas9.9的分子机制.
- 确定AcrIIA26调节SpyCas9活动的结构基础.
主要方法:
- 电子显微镜 (cryo-EM) 用于确定SpyCas9-sgRNA-AcrIIA26复合物的结构.
- 结构分析以了解蛋白质-蛋白质和蛋白质-核酸相互作用.
主要成果:
- 冷-EM结构揭示了AcrIIA26的两个域架构.
- AcrIIA26通过其5A和4A域与SpyCas9结合,从而阻碍了目标DNA的结合和分裂.
- AcrIIA26独立于sgRNA结合Cas9,使时间调节延长.
结论:
- AcrIIA26通过物理阻断DNA结合和基本形状变化来抑制SpyCas9.
- 这种sgRNA独立的结合机制为精确控制SpyCas9基因编辑应用提供了新的策略.
相关概念视频
CRISPR
58.2K
Genome editing technologies allow scientists to modify an organism’s DNA via the addition, removal, or rearrangement of genetic material at specific genomic locations. These types of techniques could potentially be used to cure genetic disorders such as hemophilia and sickle cell anemia. One popular and widely used DNA-editing research tool that could lead to safe and effective cures for genetic disorders is the CRISPR-Cas9 system. CRISPR-Cas9 stands for Clustered Regularly Interspaced...
58.2K
The Antiviral System of Bacteria and Archaea: CRISPR
801
CRISPR stands for Clustered Regularly Interspaced Short Palindromic Repeats is a adaptive immune system found in bacteria and archaea that protects against viral infections. This system enables prokaryotic cells to identify, remember, and neutralize foreign genetic elements, primarily bacteriophages, by storing fragments of the invader’s DNA as a genetic memory.The CRISPR immune response begins during an initial infection. Cas (CRISPR-associated) proteins play a central role in this...
801
CRISPR and crRNAs
19.3K
Bacteria and archaea are susceptible to viral infections just like eukaryotes; therefore, they have developed a unique adaptive immune system to protect themselves. Clustered regularly interspaced short palindromic repeats and CRISPR-associated proteins (CRISPR-Cas) are present in more than 45% of known bacteria and 90% of known archaea.
The CRISPR-Cas system stores a copy of foreign DNA in the host genome and uses it to identify the foreign DNA upon reinfection. CRISPR-Cas has three different...
The CRISPR-Cas system stores a copy of foreign DNA in the host genome and uses it to identify the foreign DNA upon reinfection. CRISPR-Cas has three different...
19.3K
CRISPR/Cas9 Genome Editing
2.1K
The CRISPR-Cas system serves as a bacterial defense mechanism against invading genetic elements such as viruses and plasmids, forming the foundation for its adaptation as a powerful genome-editing tool. Originally discovered in prokaryotes, this system has been repurposed to revolutionize genetic engineering across a wide range of organisms, including plants, animals, and humans. The core component, Cas9, is an endonuclease derived from Streptococcus pyogenes, capable of introducing...
2.1K
Experimental RNAi
8.0K
RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
8.0K
RNA Interference
28.2K
RNA interference (RNAi) is a process in which a small non-coding RNA molecule blocks the post-transcriptional expression of a gene by binding to its messenger RNA (mRNA) and preventing the protein from being translated.
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
28.2K


